Way to Be Active III (Framing Incentives)

N/ACompletedNCT02030119

University of Pennsylvania281 enrolled

Overview

Employers are increasingly looking for opportunities to motivate sedentary employees to become more physically active. Workplace walking programs have had mixed success and typically show most improvement among participants that are already fairly active at a baseline. The goal of this study is to determine whether a financial incentive program can motivate sedentary employees to increase the number of steps they walk per day to meet a minimum threshold. The primary outcome measure is the proportion of days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives. Secondary outcomes will include the average steps walked per day.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Enrollment

281

Conditions

Sedentary Lifestyle

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age greater than 18. 2. Participant will need an iPhone or Android smartphone to be able to use the Moves App for tracking steps Exclusion Criteria: 1. A score of "high" on the International Physical Activity Questionnaire (IPAQ) activity level scale 2. BMI less than 27 3. Pregnant or lactating 4. Participation in another physical activity study

Outcomes

Primary Outcomes

Proportion of Days Each Individual Walks 7000 Steps Per Day or More

The primary outcome measure is the mean proportion of participant-days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives.

Time frame: Throughout the 6 month study

Secondary Outcomes

Average Number of Steps Per Day

Secondary outcomes include average number of steps each individual takes per day throughout the 13-week intervention and additional 13-week follow-up periods.